NCT06487624
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06487624
Title An Engineered Sirpa Fused to Anti-Pd-L1 And Tgf-b Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors FBD Biologics Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Prisma Health-Upstate RECRUITING Greenville South Carolina 29605 United States Details
The First Affiliated Hospital, Zhejiang University School of Medicine RECRUITING Hangzhou China Details
Zhejiang Provincial Cancer Hospital RECRUITING Hangzhou China Details
Xuzhou Central Hospital RECRUITING Xuzhou China Details
Yantai Yuhuangding Hospital RECRUITING Yantai China Details
Southern Medical University Zhujiang Hospital RECRUITING Zhujiang China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field